Three peptides dominate the "serious" end of the nootropic peptide conversation: Semax, Selank, and Cerebrolysin. They're frequently discussed together, often grouped as "Russian peptides" (imprecise but culturally accurate), and share the characteristic of having more research behind them than the typical biohacker peptide — but most of that research is in Russian and lacks Western RCT replication.
This article is a head-to-head evidence review. What each does, what the research actually shows, what the regulatory situation is, and who might consider them seriously.
Important upfront: Explorer Health does not sell peptides. This article is editorial. None of these compounds are FDA-approved in the United States; purchase and use exist in legal gray zones. Nothing here is a recommendation to purchase or use these substances.
The three compounds at a glance
| Semax | Selank | Cerebrolysin | |
|---|---|---|---|
| Type | Synthetic heptapeptide | Synthetic heptapeptide | Porcine brain-derived peptide mix |
| Based on | ACTH(4-10) fragment | Tuftsin analog | Multiple neurotrophic factors |
| Primary mechanism | BDNF upregulation, monoaminergic | GABA modulation, monoaminergic | Multi-factor neurotrophic mimetic |
| Route | Intranasal | Intranasal | Injection (IM/IV) |
| Evidence base | Moderate (mostly Russian) | Moderate (mostly Russian) | Substantial (200+ trials global) |
| Approved uses | Stroke (Russia) | Anxiety disorders (Russia) | Alzheimer's, stroke, TBI (40+ countries, not US) |
| Primary appeal | Cognitive enhancement, recovery | Anxiolytic without sedation | Neurological recovery |
Semax: the BDNF peptide
What it is
Semax is a synthetic heptapeptide: Met-Glu-His-Phe-Pro-Gly-Pro. It's a stable fragment derived from adrenocorticotropic hormone (ACTH), modified to resist enzymatic breakdown.
Mechanism
The evidence (emerging): Semax has several demonstrated mechanisms:
- BDNF upregulation — Animal studies show Semax increases BDNF protein by approximately 1.4-fold and BDNF mRNA by about 3-fold in relevant brain regions. BDNF (brain-derived neurotrophic factor) is the best-studied neurotrophin for cognitive enhancement, memory, and neuroprotection.
- TrkB receptor modulation — Increases the receptor for BDNF, amplifying the effect.
- Monoaminergic effects — Modulates serotonin, dopamine, and acetylcholine systems without direct receptor agonism.
- Neuroprotection — Demonstrates protective effects in animal models of ischemia, oxidative stress, and neurodegeneration.
Clinical evidence
Stroke rehabilitation (primary Russian indication): Russian clinical trials have shown Semax accelerates motor and cognitive recovery when added to standard stroke care. The evidence base supports its use in this indication within Russian medicine but has limited Western RCT replication.
Healthy adult cognitive enhancement: Limited peer-reviewed evidence. Self-report is extensive in nootropic communities; controlled trials in healthy populations are sparse.
ADHD, cognitive complaints: Some small clinical trials support use; methodology is variable.
Administration
Intranasal solution, typically 0.1% or 1% concentration. Nasal delivery uses the olfactory pathway for partial bypass of the blood-brain barrier.
Typical research dose range: 300-900 mcg per nostril, 1-3 times daily. Cycled (typically 2-3 weeks on, then break).
Safety profile
Generally well-tolerated in published research. Reported side effects: - Overstimulation if dosed late in day - Sleep disruption - Nasal irritation - Occasional irritability at higher doses
Cautions: - Avoid combination with SSRIs, MAOIs, or other serotonergic drugs - Caution in psychiatric conditions — BDNF upregulation may not be uniformly beneficial - Long-term safety data in healthy adults is limited
The honest assessment
Semax has real mechanism and real Russian clinical evidence for stroke rehabilitation. For healthy adults using it as a nootropic, the evidence is thinner than the online enthusiasm suggests. The user community reports tend to be positive, but placebo effects and expectation effects are strong in this category.
Selank: the anxiolytic peptide
What it is
Selank is a synthetic heptapeptide: Thr-Lys-Pro-Arg-Pro-Gly-Pro. It's a modified analog of tuftsin, a natural tetrapeptide with immunomodulatory properties.
Mechanism
The evidence (emerging): Selank has a distinctive mechanism profile:
- GABA-A receptor modulation — Allosteric enhancement of GABA-A signaling. Unlike benzodiazepines, this modulation appears to produce anxiolytic effects without sedation, cognitive impairment, or dependence liability.
- Monoaminergic effects — Affects serotonin and norepinephrine systems.
- Immunomodulation — Inherited from its tuftsin-analog origin; may have broader immune effects.
- BDNF effects — Some evidence of BDNF modulation, though less pronounced than Semax.
Clinical evidence
Generalized anxiety disorder (primary Russian indication): Multiple Russian clinical trials support Selank for anxiolytic use. Comparison trials with benzodiazepines (primarily Medazepam) show comparable efficacy with reportedly better side effect profile and absence of sedation.
Asthenic and neurotic conditions: Used in Russian medicine for stress-related conditions.
Cognitive effects: Some evidence of memory and attention improvement, particularly in stress-related cognitive complaints.
Administration
Intranasal (0.15% solution typical). Typical research dose: 250-500 mcg/day in divided doses. Cycled courses of 14-21 days.
Safety profile
Favorable short-term profile in published research: - No dependence liability reported - No sedation - No cognitive impairment - Mild or absent side effects
Cautions: - Long-term human safety data is limited - Immunomodulation mechanism may be relevant in specific conditions - Product purity and dose accuracy depend entirely on vendor
The honest assessment
Selank is the more distinctive compound in this trio. An anxiolytic that doesn't cause sedation or dependence would be clinically valuable if the evidence replicates in Western trials. For people with anxiety, it's a more compelling target than Semax is for cognition.
However, the supply chain reality — unregulated vendor products with variable purity — is a material barrier. Someone genuinely interested in anxiolytic peptides should pursue this through a responsible clinician, not via online purchase.
Cerebrolysin: the clinically established one
What it is
Cerebrolysin is categorically different from Semax or Selank. It's not a single synthetic peptide — it's a standardized preparation of low-molecular-weight neuropeptides and free amino acids, produced from purified porcine brain protein through controlled enzymatic breakdown.
All components are under 10 kDa, allowing blood-brain barrier penetration.
Mechanism
The evidence (emerging): Cerebrolysin appears to mimic the effects of several endogenous neurotrophic factors simultaneously:
- BDNF (brain-derived neurotrophic factor)
- GDNF (glial cell-derived neurotrophic factor)
- NGF (nerve growth factor)
- CNTF (ciliary neurotrophic factor)
Rather than targeting a single receptor, it provides a broad-spectrum neurotrophic effect. This may explain why its clinical evidence spans multiple indications (stroke, TBI, Alzheimer's) rather than being narrow.
Clinical evidence
This is where Cerebrolysin substantially separates from Semax and Selank.
Evidence base: - 200+ clinical trials globally - Approximately 15,000 patients in aggregate - Approved for clinical use in 40+ countries
Primary indications:
Alzheimer's disease: Multiple RCTs show improvement in Clinical Global Impression (CGI) and ADAS-cog cognitive scores. The Plosker & Gauthier 2009 meta-analysis of 6 RCTs (784 patients) found significant improvement versus placebo.
Ischemic stroke: The CARS (Cerebrolysin and Recovery After Stroke) trial and subsequent research show improvement in motor function recovery and reduction of disability scores.
Traumatic brain injury: Accelerated recovery of cognitive function in moderate TBI.
Vascular dementia: Slowed cognitive decline in multi-trial evidence.
Administration
Injection only: intramuscular or intravenous. There is no effective oral form — the peptide mixture is inactivated by digestion.
Typical clinical protocol: 10-50 mL daily via IV infusion or IM injection, 5-day weeks, 4-6 week courses. Usually repeated annually or semi-annually.
Cost: Substantial. Not covered by US insurance since not FDA-approved. Clinical treatment courses in countries where approved typically cost $1,500-5,000.
Safety profile
Well-characterized from clinical use: - Mild adverse effects most common (headache, injection site reactions, transient agitation) - Serious adverse events rare - Long-term safety established through 40+ years of clinical use
Cautions: - Severe renal impairment - Grand mal epilepsy - Pregnancy - Hypersensitivity to animal protein
The honest assessment
Cerebrolysin is genuine medicine in most of the world. If you have a serious neurological condition Cerebrolysin treats — stroke recovery, TBI, Alzheimer's — accessing it through a responsible clinician is a reasonable conversation.
For healthy adults seeking cognitive enhancement, the cost-benefit is unfavorable. Safety data is for patients with conditions being treated, not for off-label use in healthy people. The injection requirement also makes it impractical for casual experimentation.
Which one should someone consider?
This depends entirely on the goal and context.
If the goal is cognitive enhancement in a healthy adult
None of these are strongly supported for this use. Semax has the most marketing around cognitive enhancement but limited rigorous evidence in healthy populations. Basic interventions (sleep, exercise, creatine, omega-3) have better evidence and vastly lower cost.
If the goal is anxiolytic effect
Selank is the most targeted compound if the evidence replicates. For treatment-resistant anxiety in a patient who's failed conventional options, this is the most interesting case — best pursued through a psychiatrist familiar with peptides.
If the goal is neurological recovery
Cerebrolysin is the best-evidenced option. Post-stroke, post-TBI, or in progressive cognitive decline, it's worth discussing with a neurologist or longevity-medicine specialist. Access requires either international sourcing or specialty compounding pharmacy.
If the goal is general brain health optimization
None of these. Fundamentals (exercise, sleep, omega-3, B-complex, vitamin D, stress management) produce more benefit at zero risk compared to any of these peptides.
The vendor quality problem
All three compounds, when purchased online, face the same issue: product quality depends entirely on the vendor, and most vendors don't provide independent verification.
Key quality markers if sourcing is pursued: - Third-party HPLC purity analysis (certificate of analysis per batch) - Endotoxin testing for injectable products - Temperature-controlled storage and shipping - Legitimate business with operational history
Most online peptide vendors don't meet these bars. Price is a weak signal — low prices suggest corner-cutting; high prices don't guarantee quality.
Regulatory context in the US
When to see a doctor
All three peptides are in regulatory gray zones in the United States:
- Semax: Not FDA-approved. Not a DSHEA-compliant supplement. Sold as "research chemical" online.
- Selank: Same as Semax — not approved, not a supplement, online availability is gray market.
- Cerebrolysin: Not FDA-approved. Some compounding pharmacies historically produced it; FDA has been restricting peptide compounding. International pharmacy sourcing exists but US Customs seizes shipments.
Possession for personal use typically hasn't been prosecuted, but purchase and distribution exist in legal gray zones. Sourcing through a physician who works with compounding pharmacies is the most legitimate path where still available.
Our editorial stance
We cover these peptides in detail because our audience asks about them and the online information is often either hype or dismissal. The honest middle ground:
- Cerebrolysin is real medicine. It has a legitimate clinical evidence base for specific conditions. If you have one of those conditions, it's a reasonable physician conversation.
- Semax and Selank have interesting mechanisms and modest evidence primarily from Russian clinical research that hasn't been replicated with Western RCT rigor. They're not snake oil, but the online enthusiasm typically outruns the evidence.
- The vendor ecosystem is a real barrier. Unregulated product quality means that even if the mechanisms were fully established, knowing what you're getting is a genuine problem.
- For healthy adults seeking enhancement, the evidence doesn't support the cost and risk compared to well-evidenced alternatives.
- For people with specific clinical indications, working with a physician who understands these compounds is the appropriate path.
What we'd recommend instead for most goals
For cognition in a healthy adult: - Exercise (zone 2 + resistance training) — BDNF elevation with strong evidence - Sleep optimization - Omega-3 2g/day - Creatine 5g/day - Daily practice of a cognitively demanding skill
For anxiety: - Therapy (CBT, ACT, or similar evidence-based approaches) - Exercise - Mindfulness practice - L-theanine 200mg for acute episodes - Medical evaluation if anxiety is significant
For post-stroke or post-TBI recovery: - Standard rehabilitation protocols are the foundation - Discussion of Cerebrolysin with a neurologist - Physical therapy, occupational therapy, speech therapy as indicated - Social support
These paths have better evidence-to-cost ratios than peptide experimentation.
Your evidence-tiered protocol
Our 5-minute brain health quiz generates a personalized protocol based on the strongest-evidence interventions for your specific goals — including when peptide consideration might be worth discussing with a specialist.
**Take the Explorer Health Quiz →**
This article is a cluster under our main pillar on nootropic peptides.
---
Frequently Asked Questions
What's the difference between Semax and Selank?
Semax primarily upregulates BDNF and has modest monoaminergic effects — it's positioned for cognitive enhancement and recovery. Selank primarily modulates GABA-A receptors with additional monoaminergic effects — it's positioned as an anxiolytic without sedation. They share administration route (intranasal) and origin (Russian pharmaceutical research).
Which peptide has the best evidence for brain health?
Cerebrolysin has the strongest evidence base — 200+ clinical trials and approval for clinical use in 40+ countries (though not the US). It's specifically evidenced for neurological recovery (stroke, TBI) and dementia, not general cognitive enhancement. For healthy adults seeking nootropic effects, no peptide has strong evidence.
Are Semax and Selank legal in the US?
Neither is FDA-approved, and neither qualifies as a DSHEA-compliant dietary supplement. They're sold online as "research chemicals" in a legal gray zone. Personal use possession hasn't typically been prosecuted, but purchase and distribution exist in unclear legal territory.
How do you take Semax and Selank?
Both are administered intranasally (nasal drops or spray). Typical research doses: Semax 300-900 mcg per nostril 1-3x daily; Selank 250-500 mcg/day in divided doses. Both are typically cycled (2-3 weeks on, then break).
Can you take Semax and Selank together?
Some users combine them (Semax for cognitive effect, Selank for anxiolytic). The combination hasn't been rigorously studied; interactions haven't been well-characterized. Most practitioners who work with peptides recommend not stacking without specific reason.
What are the side effects of peptide nootropics?
Reported effects vary by compound: Semax can cause overstimulation, sleep disruption, and occasional irritability; Selank typically has mild effects if any; Cerebrolysin can cause headache, injection site reactions, and mild agitation. Long-term safety in healthy adults is not well-characterized for any of these.
Why aren't peptides like these FDA-approved?
FDA approval requires Phase 1-3 clinical trials costing $1-3 billion. Peptides are typically off-patent or difficult to patent effectively, removing commercial incentive for sponsors. This is a systemic problem, not evidence that the compounds don't work — but it means that the rigorous Western RCT evidence base isn't present.
Is Cerebrolysin safe to use long-term?
Cerebrolysin has been used clinically for 40+ years in the countries where it's approved, with a well-characterized safety profile. Treatment courses are typically cycled (4-6 weeks of treatment, repeated annually or semi-annually) rather than continuous. For approved indications under medical supervision, long-term safety is established.
Can you buy real Semax online?
Semax is sold extensively online through "research chemical" vendors. Product quality varies enormously; most vendors don't provide third-party verification. Even products that are chemically Semax may have purity issues, dose accuracy problems, or contamination. The vendor ecosystem lacks the quality infrastructure of the legitimate pharmaceutical supply chain.
Should I try peptides for brain fog?
No — not as a first step. Brain fog has many treatable causes (sleep, stress, nutrition, hormones, specific deficiencies, thyroid issues). Start with sleep optimization, basic bloodwork (including vitamin D, B12, thyroid, ferritin), and ruling out treatable medical causes. Peptides are expensive, unregulated, and have insufficient evidence for this indication.
---
References
References
- Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97 Suppl 1:82-86.
- Kaplan AY, Kochetova AG, Nezavibathko VN, et al. Synthetic ACTH Analogue Semax Displays Nootropic-like Activity in Humans. Neurosci Res Commun. 1996;19:115-123.
- Shadrina MI, Dolotov OV, Grivennikov IA, et al. Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neurosci Lett. 2001;308(2):115-118.
- Zozulya AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic drug Selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
- Medvedev VE, Tereshchenko OA, Kost NV, et al. Peptide anxiolytic Selank: experience of use in outpatient psychiatric practice. Soc Clin Psychiatr. 2014;24(2):68-75.
- Plosker GL, Gauthier S. Cerebrolysin: a review of its use in dementia. Drugs & Aging. 2009;26(11):893-915.
- Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016;47(1):151-159.
- Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2013;(1):CD008900.
- Thome J, Doppler E. Safety profile of Cerebrolysin: clinical experience from neurological and psychiatric indications. Clin Drug Investig. 2018;38(6):527-537.
- Gusev EI, Skvortsova VI, Izykenova GA, et al. The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 1996;96(5):68-72.
- US Food and Drug Administration. Bulks List Category 2: Substances Under Evaluation for 503A Compounding. [FDA policy document, 2023].
- Volkova A, Bardakov V, Zhukova E, et al. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation. ACS Chem Neurosci. 2022;13(21):3106-3114.
---
Medical disclaimer and regulatory note: Nothing in this article constitutes medical advice or a recommendation to purchase any specific product. The peptides discussed exist in a legal gray zone in the United States. Possession, purchase, and use may have legal and health consequences. Consult a qualified physician before considering peptide therapy.